The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Editorial Policy Advisory Group
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Frontiers in Neurology
(Mar 2023)
Commentary: Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies
Joseph R. Berger,
Hans-Peter Hartung,
Hans-Peter Hartung,
Hans-Peter Hartung
Affiliations
Joseph R. Berger
Department of Neurology, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, PA, United States
Hans-Peter Hartung
Department of Neurology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany
Hans-Peter Hartung
Brain and Mind Center, University of Sydney, Sydney, NSW, Australia
Hans-Peter Hartung
Department of Neurology, Palacky University, Olomouc, Czechia
DOI
https://doi.org/10.3389/fneur.2023.1146027
Journal volume & issue
Vol. 14
Abstract
Read online
No abstracts available.
Keywords
progressive multifocal leucoencephalopathy (PML)
multiple sclerosis
natalizumab
risk factors
immunogenetics
WeChat QR code
Close